Recent treatment advances and practical management of hepatitis D virus.
Olsen, Kathryn Mahgoub, Sara Al-Shakhshir, Sarah Algieder, Akram Atabani, Sowsan Bannaga, Ayman Elsharkawy, Ahmed M
Olsen, Kathryn
Mahgoub, Sara
Al-Shakhshir, Sarah
Algieder, Akram
Atabani, Sowsan
Bannaga, Ayman
Elsharkawy, Ahmed M
Citations
Altmetric:
Affiliation
Olsen, Kathryn; Mahgoub, Sara; Al-Shakshir, Sarah; Algleder, Akram; Sowsan, Atabani; Bannaha, Ayman; Elsharkawy. A.
Other Contributors
Publication date
2023-06-23
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Hepatitis D virus (HDV), also referred to as hepatitis delta virus, is the smallest virus capable of causing human disease. It is unable to replicate on its own and can only propagate in the presence of hepatitis B virus (HBV). Infection with both HBV and HDV frequently results in more severe disease than HBV alone, with higher instances of cirrhosis, liver failure and hepatocellular carcinoma (HCC). Thus, there is a need for effective treatment for HDV; however, currently approved treatment options are very limited both in terms of their efficacy and availability. This makes the management of HDV a challenge for physicians. In this review, we look at the background, diagnosis and treatment of HDV, informed by our hospital data, to set out the optimal management of HDV; we also explore novel treatment options for this disease.
Citation
Olsen K, Mahgoub S, Al-Shakhshir S, Algieder A, Atabani S, Bannaga A, Elsharkawy AM. Recent treatment advances and practical management of hepatitis D virus. Clin Med (Lond). 2023 Jun 23:clinmed.2022-0556. doi: 10.7861/clinmed.2022-0556. Epub ahead of print.
Type
Article